In breast and ovarian tumors, crosstalk between mitochondria and NADPH oxidase requires mitochondrial production of ROS and Nox1 [65], and loss of Nox1 signaling contributes to breast and ovarian tumorigenesis [65]. The gene discussed is FMO5; the disease is ovarian neoplasm.